GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biocon Ltd (BOM:532523) » Definitions » Additional Paid-In Capital

Biocon (BOM:532523) Additional Paid-In Capital : ₹0 Mil(As of Dec. 2023)


View and export this data going back to 2004. Start your Free Trial

What is Biocon Additional Paid-In Capital?


Biocon's annual additional paid-in capital increased from Mar. 2021 (₹3,236 Mil) to Mar. 2022 (₹3,847 Mil) and increased from Mar. 2022 (₹3,847 Mil) to Mar. 2023 (₹4,390 Mil).


Biocon Additional Paid-In Capital Historical Data

The historical data trend for Biocon's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biocon Additional Paid-In Capital Chart

Biocon Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Additional Paid-In Capital
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,171.00 238.00 3,236.00 3,847.00 4,390.00

Biocon Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 4,390.00 - - -

Biocon Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

Biocon Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Biocon's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.


Biocon (BOM:532523) Business Description

Industry
Traded in Other Exchanges
Address
20th KM, Hosur Road, Electronics City, Bengaluru, KA, IND, 560 100
Biocon Ltd is a biopharmaceutical company that develops biotechnology therapies for diseases. The company is focused on developing, manufacturing, and supplying novel and biosimilar pharmaceuticals for diabetes, cancer, and autoimmune conditions. Biocon has four reportable segments: Generics, Biosimilars, Novel Biologics (Novels), and Research services (Research). The company provides integrated contract research and manufacturing services to pharmaceutical and biotechnology companies through its subsidiary Syngene.

Biocon (BOM:532523) Headlines

No Headlines